Additionally, CD163 and MCP-1 in the inflammatory lesions and the fold change upon ICI treatment in expression levels on monocytes in blood tended to be associated with ICI-induced autoimmune conditions [20, 164, 170, 172]. Here, CCL2 is linked to Autoimmunity.